K-numberK241781
Device nameSolo Pace Control
ApplicantSolo Pace, Inc.
Product codeDTE
Device classClass II
Decision dateJan 10, 2025
DecisionSubstantially Equivalent
Regulation870.3600
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Solo Pace Control is an external cardiac pacemaker pulse generator designed for temporary single-chamber pacing in clinical environments, primarily for interventional cardiology procedures. It is used with a cardiac pacing lead system to provide short-term demand pacing for conditions including complete heart block, bradycardia, and cardiac complications during procedures, with continuous patient monitoring required.

Technological characteristics

Solo Pace Control provides sensing and pacing functions similar to the predicate Medtronic 5392 but with a simplified design including only features necessary for single-chamber pacing in the catheterization laboratory. Key differences include AC main power with battery backup, bed-mountable form factor, assistive operational workflow stages (pacing capture check, rapid pacing, control pacing, back-up pacing), Bluetooth-enabled remote control capability, and pre-sets organized around interventional structural heart procedures.

Test standards cited

IEC 60601-1 (electrical safety), IEC 60601-1-2 (EMC), IEC 60601-4-2 (immunity), IEC 60601-2-31 (external pacemaker safety and performance), ANSI C63.27-2001 and AAMI C63.270-2021 (wireless coexistence evaluation), plus system and subsystem verification testing, software validation, cybersecurity risk management, and design validation with clinical users.

Substantial equivalence argument

Both devices are external pulse generators for temporary cardiac pacing in clinical environments using the same regulatory classification and product code. Although Solo Pace Control is simplified for interventional cardiology and adds Bluetooth remote control and workflow-specific presets, these design differences represent non-fundamental modifications that do not introduce new safety or performance risks. Performance testing met specified acceptance criteria across all standard electrical safety, EMC, wireless, and pacemaker-specific tests, demonstrating the simplified design and new features do not raise new safety or effectiveness issues compared to the predicate.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →